Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostatetissue

Prostate

Volumn 69, Issue 1, 2009, Pages 62-69

  Van Niekerk, Cornelis G ^a   Van Der Laak, Jeroen A W M ^a   Börger, M Elisa ^a   Huisman, Henk Jan ^a   Witjes, J Alfred ^a   Barentsz, Jelle O ^a   De Kaa, Christina A Hulsbergen Van ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Digital image analysis; Microvasculature; Prostate cancer; Quantification; Whole slide scanning

Indexed keywords

CONTRAST MEDIUM; CD31 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER SYSTEM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIGITAL IMAGING; EARLY CANCER; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCANNING ELECTRON MICROSCOPY; TISSUE SECTION; TUMOR VASCULARIZATION; ADENOCARCINOMA; CYTOLOGY; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MICROSCOPY; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROSTATE; PROSTATE TUMOR; VASCULARIZATION;

ADENOCARCINOMA; AGED; ANTIGENS, CD31; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 58149345609     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20855     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin 2008;58:71-96.
2. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
3. Carnochan P, Briggs JC, Westbury G, Davies AJ. The vascularity of cutaneous melanoma: A quantitative histological study of lesions 0.85-1.25 mm in thickness. Br J Cancer 1991;64:102-107.
4. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-1124.
5. Sotiropoulou M, Diakomanolis E, Elsheikh A, Loutradis D, Markaki S, Michalas S. Angiogenic properties of carcinoma in situ and microinvasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 2004;25:219-221.
6. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72:319-323.
7. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
8. Pallares J, Rojo F, Iriarte J, Morote J, Armadans LI, de T I. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol 2006;21:857-865.
9. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993;24:220-226.
10. Arakawa A, Soh S, Chakraborty S, Scardino PT, Wheeler TM. Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 antigen). Prostate Cancer Prostatic Dis 1997;1:32-38.
11. Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol 1998;160:459-465.
12. Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, de la TA, Katz AE, Olsson CA, Ennis RD. Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 1999;53:542-547.
13. Gettman MT, Bergstralh EJ, Blute M, Zincke H, Bostwick DG. Prediction of patient outcome in pathologic stage T2 adenocar-cinoma of the prostate: Lack of significance for microvessel density analysis. Urology 1998;51:79-85.
14. De la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, Burchardt T, Ennis RD, Rubin MA. Microvessel density as a predictor of PSA recurrence after radical prostatectomy-A comparison of CD34 and CD31. Am J Clin Pathol 2000;113:555-562.
15. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
16. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
17. van der Laak JA, Westphal JR, Schalkwijk LJ, Pahlplatz MM, Ruiter DJ, de Waal RM, de Wilde PC. An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model. J Pathol 1998;184:136-143.
18. Fox SB, Gatter KC, Altman DG, Leek RD, Harris AL. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:1798-1799.
19. Belien JA, Somi S, de Jong JS, van Diest PJ, Baak JP. Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 1999;52:184-192.
20. Sakai I, Harada K, Hara I, Eto H, Miyake H. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 2005;96:528-532.
21. Ruijter ET, Miller GJ, Aalders TW, van de Kaa CA, Schalken JA, Debruyne FM, Boon ME. Rapid microwave-stimulated fixation of entire prostatectomy specimens. Biomed-II MPC Study Group. J Pathol 1997;183:369-375.
22. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228-1242.
23. van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. Clin Cancer Res 2005;11:1899-1909.
24. Weibel ER. Stereological methods. London: Academic Press; 1979.
25. Sokal RR, Rohlf FJ. Biometry: The principles and practice of statistics in biological research. 2nd edition. New York: W.H. Freeman and Company; 1981.
26. De Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY, Cheng L, Datta M, Egevad L, Ertoy-Baydar D, Farre X, Fine SW, Iczkowski KA, Ittmann M, Knudsen BS, Loda M, Lopez-Beltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Pikarsky E, Pizov G, Rubin MA, Samaratunga H, Sebo T, Sesterhenn IA, Shah RB, Signoretti S, Simko J, Thomas G, Troncoso P, Tsuzuki TT, van Leenders GJ, Yang XJ, Zhou M, Figg WD, Hoque A, Lucia MS. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 2006;30:1281-1291.
27. Kaygusuz G, Tulunay O, Baltaci S, Gogus O. Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue. Int Urol Nephrol 2007;39:841-850.
28. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies. Cancer Res 2000;60:1388-1393.
29. Chalkey HW. Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 1943;4:47-53.
30. Offersen BV, Borre M, Overgaard J. Quantification of angio-genesis as a prognostic marker in human carcinomas: A critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 2003;39:881-890.
31. Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol 1966;30:23-38.
32. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988;96:379-394.
33. Hannen EJ, van der Laak JA, Kerstens HM, Cuijpers VM, Hanselaar AG, Manni JJ, de Wilde PC. Quantification of tumour vascularity in squamous cell carcinoma of the tongue using CARD amplification, a systematic sampling technique, and true colour image analysis. Anal Cell Pathol 2001;22:183-192.
34. Boyle J. Histological measurement of tumour angiogenesis. Eur J Cancer 2003;39:859-860.
35. Fox SB, Harris AL. Histological quantitation of tumour angio-genesis. APMIS 2004;112:413-430.
36. de Jong JS, van Diest PJ, Baak JP. Heterogeneity and reprodu-cibility of microvessel counts in breast cancer. Lab Invest 1995;73:922-926.
37. Hansen S, Grabau DA, Rose C, Bak M, Sorensen FB. Angio-genesis in breast cancer: A comparative study of the observer variability of methods for determining microvessel density. Lab Invest 1998;78:1563-1573.
38. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94:883-893.
39. Erbersdobler A, Fritz H, Schnoger S, Graefen M, Hammerer P, Huland H, Henke RP. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: Differences between tumours located in the transition zone and in the peripheral zone. Eur Urol 2002;41:40-46.